SUBSTITUTED 4-(6-FLUORO-(1H)-INDOL-3-YL)-1,2,3,6-TETRAHYDROPYRIDINE FOR THE TREATMENT OF CNS-DISORDERS

摘要

A pharmaceutical compound of formula (I), in which R<1> is hydrogen, C1-4 alkyl, C1-4 alkoxy or halo, and R<2> is hydrogen, C1-4 alkyl or C1-4 alkoxy; or a salt thereof. The compounds of the invention and their pharmaceutically acceptable salts are indicated for use in the treatment of disorders of the central nervous system.